Evaluation of a new serum tumor marker CYFRA 21.1 for the diagnosis and prognosis of non small cell lung cancer (NSCLL): Preliminary results

Evaluation of a new serum tumor marker CYFRA 21.1 for the diagnosis and prognosis of non small cell lung cancer (NSCLL): Preliminary results

40 150 151 PROGNOSTIC VALllE OF THE NEW TUMOR MARKER CZFRA 21-1 IN NON-SMALL CELL LUNG CANCFX. J.Niklihski, M.Furman, E. Chyczewska, L.Chyczewski, F...

152KB Sizes 3 Downloads 114 Views

40 150

151

PROGNOSTIC VALllE OF THE NEW TUMOR MARKER CZFRA 21-1 IN NON-SMALL CELL LUNG CANCFX. J.Niklihski, M.Furman, E. Chyczewska, L.Chyczewski, F.Rogowski, J.LaudaAski Departments of: Thoracic Surgery, Pneumonology, Pathology and Nuclear Medicine, Medical School, Bialystok, Poland Cytokeratin 19 is particular-y abundant in lung carcinoma. 85 patients (pts) with non-small cell lung cancer- NSCLC (58bperable, 15 unresectable tumors, 12 proved distance metastasis) were investigated to establish CYFRA 21-1 serum utility as a prognostic factor, using IRMA method (CIS bio GIF-SUR-YVETTE).CYFRA 21-1 assays were performed before surgery and serially after tumor resection. In the 73 pts qualified for thoracotomy, increased CYFRA 21-1 levels were observed in 52% (33% of stage I, 47% of stage II, 57% of stage IIIa, 67% of stage IIIb). In 12 pts with TNM IV CYFRA 21-1 elevated levels were obtained in 75% CYFRA 21-1 levels were significantly lower in 58 pts with resectable tumors than in 15 cases with unresectable (p< 0.02). The study proved that CYFRA 21-1 preoperative determination and the course of levels of this marker during follow-up was important. Pretreatment elevation resulted in poorer patient survival. Complete resection resulted in a significant drop in serum CYFRA 21-1 levels in 16 pts who had elevated marker level before surgery and no further disease evidence. In 14 of 58 who survived complete resection, recurrence were subsequently detected. The percentage of recurrence in patients with normal postoperative CYFRA 21-1 levels was 2.3% (l/43). The percentageof recurrence in pts with CYFRA postoperative elevated levels was significantlyhigher and equaled 87% (13/15). In 11 of 13 pts with recurrence after complete resection, recurrent elevation of CYFRA 21-1 preceded changes detectable by CT or clinical examination by 2 to 6 months. In conclusion, CYFRA 21-1 appears to be a useful prognostic marker in NSCLC.

ROLE OF ELASTOTIC FRAMEWORK ON THE TUMOR DEVELOPMENT OF PERIPHERAL LUNG ADENOCARCINOMA LESS THAN 4 CM IN DIAMETER.

T. Eto, H. Suzula, A. Honda,and Y.Nagashima.Shizuoka General Hospital, Shizuoka, Japan. Two hundred six patients of peripheral lung adenocarcinoma (PLA) less than 4 cm in diameter were studied histologically, morphometrically, radiographically and clinicopathologically in special reference to the stromal elastosis. We classified PLA mto two types from the stromal elastotic framework (FFW). Type 1(24 patients) had the preserved EFW consisting of constantly thick stroma. Type 2 (182 patients) revealed the disrupted EFW especially in the center of tumor forming central fibrosis (CF) where many air spaces were collapsed or collagenized. At the periphery of type 2, extending stroma (Exst) was formed with thin walled elastic framework similar to normal alveoli (NA). From the image analysis, increased amounts of elastic fibers could be calculated in type 1 ( 3.3-9.7 fold) and type 2 ( 3.9-7.6 fold) EFW compared to NA, which mean the contraction rate of pre-existing NA. In contrast, Exst in type 2 contained 0.8-2.1 fold of the fibers compared to NA suggesting mild-reacting pre-existing NA. Radiographically, in type 1, tumor size hardly enlarged and the density tended to increase gradually over a long time. In type 2, tumor size tended to increase abruptly over a short time. As prognosis of patients who were followed more than 3 years, 50% had relapsed in type 2, but none in type 1. Conclusion ; Tumor stroma in the early stage of PLA might show the preserved EFW (type 1) formed by contractmg and thickening reaction of NA. As tumor developing, disrupted EFW (type 2) form CF with Exst. It indicate the stromal invasion and directly reflect to the prognosis.

153

152 EVALUATION

OF

A

NEW

21.1 FOR THE DIAGNOSIS

SERUM TUMOR MARKER CYFRA

AND PROGNOSIS OF NON SMALL CELL LUNG CANCER (NSCLL) PRELIMINARY RESULTS. JM. Br&hot*, J.Nataf**, J.F&ult**, MF.D&*, B. Tbirion***, J.Miltgen*, J. Rochemaure* - * Service de F’neumologie, ** Labaatoire Biophysique, H&lDia. 75004 PARIS. **I* L.abomtoire Cis-Bio intemational. m : Analysis of swum CYFRA 21.1 concentrations before. and after

:

treatment in NSCLC patients (pts), accordiig to histology, TNM, response to treatment and overall survival. Me&& Prospective study with measure by immumradiometric assay of smun concentrations of CYFRA 21.1, carcincembryonic antigen (CEA), squamous cell carcinoma antigen @CC), CA 125, CA 19.9, neumn-specific an&se (NSE) in resectableand umesectable NSCLC. I&!&:

:_

: ; 3 stage

;

w 7 pts (6 M ,1 F) 2 squamous cell (SC) carcinoma, 5 adenowcinomn (ADC) I, 2 stage II, 2 stage mA; Cylia 21-I > 3,6 ng/ml in 1 (with stage I SC carcinoma) before resection and normal after resection. GrwwII:22pts(13M,9F);llSC carcinoma, 7 ADC, 3 large cell carcinoma

;

(LCC), 1 composite (SC + small cell carcinoma) 9 stage III B, 12 stage IV, 1 stage (I). Cyiin21.1 elevatedin 13 (mean 24.1, 4.0 to 89) S/l1 SC carcinoma, 317 ADC, 2i3 LCC ; SCC elevated in 4 out of 22, always associated to ao atmormal value of Cyfm 21.1 ofserumvalue ofCyfra21.1 in the 3 Pa&l Responses, in 1 Stable Disease, in 1 Progression elevation in 1 Stable Disease and 2 Pmpssion. Conclusion preliminary study, - Cytia21.1 serumconcentmtionsarealmcwmal in9/13 SC c~~cmoma, 3/12ADC, 213 LCC. - Abnormal values of Cyiia 21.1 are more Erequently observed in advanced NSCLC (l/7 resectable pts. 1302 unresectable pts). - There is a dramatically decrease of Cyfra 21 .l ccmcentralions in the 3 responders and in the resectable patient. The study is on-going.

; reduction

: Inthis

:

; seccmdary

CHRONIC

INHALATION

MUl_TlF‘!CAL

OF

URBAN

AMBIENT

NEUROENWCRlNE

HYPERPLASIA

IN

M.

Kanisawa,

Y.

lnayama.

THE

CELL

RAT

AIRWAY

T. Shibagaki, wept. Path&,

still

uncertain

model.

This

ambient and

paper

air

induces

H. Kitamurrr. TYokohama City

facilities tow”

in

installed

university during

of the

78

by in

in

in

the

the

serial

to

mostly

exposed these

for

between the

urban derived of

the

contents ambient from

pulmonary

exposed

inhaled of

air

dust air

the for

78

densely

automobile neurcendacrine

polluted exhaust cell

of

lated

observed

was

may

the

cells

reaction peptide

adenocarcinoma

dust be

may

wz

difference

detected

results

tumor

atypical

of

positive

with gas

52

particular-

“umber

of

26,

multiple

Significant

groups These

the

examined

frequently

genera type

weeks.

in both

recorded

foci

showed

the

air.

bronchioli, were

usual

particles.

of and

calcitonine

of

in

at

were

Certain

lesion

to

Development in 2 rats

in the region

neoplastic

were

lungs

bronchi

7X weeks.

in down-

bred

sacrificed

Production

small

found

immtntohistochemically found

particles the

sections.

mid

traffic were

male

animal

Hepa-filtered

were

and

brcnchio~oalveoIar

rat

composing (CGRP).

dust

weeks

the

hyperplasia

ly

axl

Animals

experimental

papiliomas cell

SOz

gas

PapillOmaS Sixty-six

heavy

is supplied

urban

in the

rats

cancer

exhaust cell

air

with

lung

of

animal

Of

epithelium.

pollutd control

facilities

NOX.

histogically

airway

a street

experment.

cell

neuroendocrine

Nontreated

aimal

Densities

inhalation

to

AND

Schwa1

proper

automobile

rat

on

Yokohama.

and

the

exposed

the

with

of

It% Univ.

smal1

of

chronic

polluted

were

of

lacking

incidence

hyperplasia rats

to

reports

chiefly

a high

Wistar

due

INDU=s

EF’ITHELIUM.

Medicine, Yokdaama, Japan. The real cause and pathogenesis are

AIR

PAF’ILLOMAS

only

in

suggest

particles a possible

in human.

cause